Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
F:PCJP

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
F:PCJP
Watchlist
Price: 0.1145 EUR 6.61% Market Closed
Market Cap: €28.7m

Wall St Price Targets

PCJP Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast PCJP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCJP is 0.3874 EUR with a low forecast of 0.2548 EUR and a high forecast of 0.5706 EUR.

Lowest Forecast
Price Target
0.2548 EUR
123% Upside
Average Forecast
Price Target
0.3874 EUR
238% Upside
Highest Forecast
Price Target
0.5706 EUR
398% Upside
Abeona Therapeutics Inc Competitors:
Price Targets
AYTU
Aytu Biopharma Inc
281% Upside
AFYA
Afya Ltd
20% Upside
CIGI
Colliers International Group Inc
19% Upside
QLYS
Qualys Inc
41% Upside

Revenue
Forecast

9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-95%
Average Miss
N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-95%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCJP's stock price target?
Price Target
0.3874 EUR

According to Wall Street analysts, the average 1-year price target for PCJP is 0.3874 EUR with a low forecast of 0.2548 EUR and a high forecast of 0.5706 EUR.

What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
16%

The compound annual growth rate for Net Income over the next 8 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett